Ravi Prakash Arya

Ravi Prakash Arya

Auto-generated profile, based on publicly available information

Ravi Prakash Arya

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Kjersti AagaardKjersti Aagaard
Kjersti Aagaard
ALAnismrita Lahon
Anismrita Lahon
MSMelissa A. Suter
Melissa A. Suter
RARavi P. Arya
Ravi P. Arya
MSMaxim D. Seferovic
Maxim D. Seferovic
RRRebecca Rico-Hesse
Rebecca Rico-Hesse
Zika virus (ZIKV) is an emerging mosquito-borne (Aedes genus) arbovirus of the Flaviviridae family. Although ZIKV has been predominately associated with a mild or asymptomatic dengue-like disease, its appearance in the Americas has been accompanied by a multi-fold increase in reported incidence of fetal microcephaly and brain malformations. The source and mode of vertical transmission from mother to fetus is presumptively transplacental, although a causal link explaining the interval delay between maternal symptoms and observed fetal malformations following infection has been missing. In this study, we show that primary human placental trophoblasts from non-exposed donors (n = 20) can be infected by primary passage ZIKV-FLR isolate, and uniquely allowed for ZIKV viral RNA replication when compared to dengue virus (DENV). Consistent with their being permissive for ZIKV infection, primary trophoblasts expressed multiple putative ZIKV cell entry receptors, and cellular function and differentiation were preserved. These findings suggest that ZIKV-FLR strain can replicate in human placental trophoblasts without host cell destruction, thereby serving as a likely permissive reservoir and portal of fetal transmission with risk of latent microcephaly and malformations.

1 May 2017 in Antiviral Research
Verified
Journal Article
Closed access
WTWenqian Tao
Wenqian Tao
BHBrett L. Hurst
Brett L. Hurst
ASAkhilesh Kumar Shakya
Akhilesh Kumar Shakya
JUJasim Uddin
Jasim Uddin
RIRohan S.J. Ingrole
Rohan S.J. Ingrole
HGHarvinder Singh Gill
Harvinder Singh Gill

17 May 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MVMegan B Vogt
Megan B Vogt
ALAnismrita Lahon
Anismrita Lahon
RARavi P Arya
Ravi P Arya
AKAlexander R Kneubehl
Alexander R Kneubehl
JCJennifer L Spencer Clinton
Jennifer L Spencer Clinton
RRRebecca Rico-Hesse
Rebecca Rico-Hesse
Mosquito saliva is a very complex concoction of >100 proteins, many of which have unknown functions. The effects of mosquito saliva proteins injected into our skin during blood feeding have been studied mainly in mouse models of injection or biting, with many of these systems producing results that may not be relevant to human disease. Here, we describe the numerous effects that mosquito bites have on human immune cells in mice engrafted with human hematopoietic stem cells. We used flow cytometry and multiplex cytokine bead array assays, with detailed statistical analyses, to detect small but significant variations in immune cell functions after 4 mosquitoes fed on humanized mice footpads. After preliminary analyses, at different early times after biting, we focused on assessing innate immune and subsequent cellular responses at 6 hours, 24 hours and 7 days after mosquito bites. We detected both Th1 and Th2 human immune responses, and delayed effects on cytokine levels in the blood, and immune cell compositions in the skin and bone marrow, up to 7 days post-bites. These are the first measurements of this kind, with human immune responses in whole animals, bitten by living mosquitoes, versus previous studies using incomplete mouse models and salivary gland extracts or needle injected saliva. The results have major implications for the study of hematophagous insect saliva, its effects on the human immune system, with or without pathogen transmission, and the possibility of determining which of these proteins to target for vaccination, in attempts to block transmission of numerous tropical diseases. Mosquito saliva proteins have numerous effects on the immune system, and we describe here the use of mice with a humanized immune system to study the effects of mosquito bites on human cells. Our results show that the number of immune cell types affected is much larger than previously described, and some immune responses to mosquito bites can be detected up until 7 days post-bite. The biological significance of these changes remains to be determined, but it might explain how some pathogens, such as viruses, can spread through the body in these cells, replicate to higher extents, and even remain in some tissues for far longer than detected in blood.

1 October 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VAVidya Arankalle
Vidya Arankalle
KLKavita S. Lole
Kavita S. Lole
RARavi P. Arya
Ravi P. Arya
ATAnuradha S. Tripathy
Anuradha S. Tripathy
ARAshwini Y. Ramdasi
Ashwini Y. Ramdasi
DKDeelip B. Kadam
Deelip B. Kadam
An unusually high number of severe pneumonia cases with considerable mortality is being observed with the pandemic H1N1 2009 virus infections globally. In India, all mild as well as critically ill cases were admitted and treated in the government hospitals during the initial phase of the pandemic. The present study was undertaken during this early phase of the pandemic. The role of viral load and host factors in the pathogenesis were assessed by examining 26 mild (MP), 15 critically ill patients (CIP) and 20 healthy controls from Pune, India. Sequential blood and lung aspirate samples were collected from CIP. Viral load and cytokines/chemokine levels were determined from the plasma and lung aspirates of the patients. TLR levels were determined by staining and FACS analysis. Gene profiling was done for both cells in the lung aspirates and PBMCs using TaqMan Low Density arrays. Antibody titres and isotyping was done using HA protein based ELISAs. 13/15 critically ill patients expired. All plasma samples were negative for the virus irrespective of the patient's category. Sequential lung samples from CIP showed lower viral loads questioning association of viral replication with the severity. Anti-rpH1N1-09-HA-IgG titres were significantly higher in critically ill patients and both categories circulated exclusively IgG1 isotype. Critically ill patients exhibited increase in TLR-3, 4, 7 and decrease in TLR-2 expressions. The disease severity correlated with increased plasma levels of IL1RA, IL2, IL6, CCL3, CCL4 and IL10. Majority of the immune-function genes were down-regulated in the PBMCs and up-regulated in the cells from lung aspirates of critically ill patients. No distinct pattern differentiating fatal and surviving patients was observed when sequential samples were examined for various parameters. Disease severity was associated with pronounced impairment of host immune response.

24 August 2017 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JSJennifer L Spencer
Jennifer L Spencer
ALAnismrita Lahon
Anismrita Lahon
LTLinda L Tran
Linda L Tran
RARavi P Arya
Ravi P Arya
AKAlexander R Kneubehl
Alexander R Kneubehl
RRRebecca R Rico-Hesse
Rebecca R Rico-Hesse
While Zika virus (ZIKV) is mainly transmitted by mosquitoes, numerous cases of sexual transmission have been reported during recent outbreaks. Little is known about which host cell types or entry factors aid in mediating this sexual transmission. In this study, we investigated ZIKV cell tropism by infecting 2 types of human prostate cells with 3 contemporary ZIKV isolates from persons infected in the Americas. We used real-time quantitative polymerase chain reaction and immunofluorescence analyses to measure infection and flow cytometry to detect entry factor expression. Here we show that ZIKV infects, replicates, and produces infectious virus in prostate stromal mesenchymal stem cells, epithelial cells, and organoids made with a combination of these cells. We also show that prostate cells express several well-characterized flavivirus attachment factors. In contrast, dengue virus does not infect or does not replicate in these prostate cells, although it is known to use similar receptors. Our results indicate that ZIKV favors infection of stromal cells more so than epithelial cells in organoids, possibly indicating a preference for stem cells in general. Overall, these results suggest that ZIKV replication occurs in the human prostate and can account for ZIKV secretion in semen, thus leading to sexual transmission.

21 September 2016 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ALAnismrita Lahon
Anismrita Lahon
RARavi P. Arya
Ravi P. Arya
AKAlexander R. Kneubehl
Alexander R. Kneubehl
MVMegan B. Vogt
Megan B. Vogt
NGNatalie J. M. Dailey Garnes
Natalie J. M. Dailey Garnes
RRRebecca Rico-Hesse
Rebecca Rico-Hesse
Zika virus (Flavivirus genus) is the first mosquito-borne virus known to cause high rates of microcephaly and abortion in humans. Typically, Zika virus causes a self-limiting, systemic illness; however, the current outbreak of Zika virus in the Americas has been associated with increased rates of fetal malformations and Guillain-Barré syndrome. Very few Zika virus isolates have been described in the literature, and live viruses are needed to perform studies of pathogenesis and to develop vaccines and treatments. We isolated Zika virus, strain FLR, directly from the serum of an individual infected in Barranquilla, Colombia (December, 2015). Here, we describe the patient’s clinical course and characterize strain FLR by its growth characteristics in mosquito and mammalian cells and its partial resistance to UV-inactivation. The full genome sequence of FLR was also analyzed (including the 3’ un-translated region), to determine its probable geographic origin, and to pinpoint structural differences from other Zika virus strains. We anticipate that the study of this low passage, clinical isolate of Zika virus, which is available for worldwide distribution, will help uncover the mechanisms of viral replication and host immune responses contributing to the varied and sometimes severe clinical presentations seen during the current epidemic in the Americas. Zika virus (ZIKV) is a mosquito-transmitted virus that causes a febrile illness characterized by a pronounced rash and occasional arthralgia. Serious complications from ZIKV infections were rarely reported until 2015, when Brazilian officials first reported an association between ZIKV infections and a dramatic increase in microcephaly and Guillian-Barré syndrome. Since then, ZIKV has been found in 39 countries in the Americas. Thus, the identification and characterization of ZIKV strains from the current outbreak are of utmost importance. In this study, we successfully isolated a ZIKV strain (ZIKV-FLR) from an individual who was bitten by mosquitoes while traveling in an area of Colombia that had ongoing dengue, chikungunya, and ZIKV transmission. Our analysis of the full genome sequence revealed that this virus strain may have originated in the Caribbean and was not directly imported from Brazil. We also discovered that this virus strain was partially resistant to inactivation by ultraviolet irradiation, when compared to dengue virus. Further work is needed to elucidate the underlying mechanisms behind this increased resistance and potential to cause more severe disease.